Related Experiment Videos

Development of an orally active tripeptide arginal thrombin inhibitor

R T Shuman1, P D Gesellchen

  • 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285, USA.

Pharmaceutical Biotechnology
|October 7, 1998
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos